secwatch.observer — SEC 8-K summary
======================================

Issuer:     HUMANA INC (HUM)
CIK:        0000049071
Form:       8-K
Filed at:   2023-10-11T23:59:59+00:00
Accession:  0000049071-23-000058
Event type: leadership
Sentiment:  neutral
Materiality: 0.80
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Humana names Jim Rechtin as COO and CEO successor; Broussard to step down in H2 2024
--------------------------------------------------------------------------------

- Jim Rechtin appointed President & COO effective Jan 8, 2024; will become CEO in latter half of 2024.
- Bruce Broussard, CEO since 2013, to step down as CEO in H2 2024 and remain as strategic advisor into 2025.
- Rechtin's base salary $1.1M as COO, rising to $1.25M as CEO; eligible for 150%/200% STI target levels.
- Initial equity award: $3M RSUs and $3M stock options; 2024 annual equity grant valued at $6M.
- Rechtin previously CEO of Envision Healthcare, President of OptumCare; brings value-based care experience.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/49071/000004907123000058/0000049071-23-000058-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/49071/000004907123000058/hum-20231009.htm
  HTML page:      https://secwatch.observer/filing/0000049071-23-000058

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer